SCHEMBL19098202

SCHEMBL19098202

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4ccccc4-c4ccc(C56CC7CC(CC(C7)C5)C6)cc4)cc3)c3ccc4c(c3)C(C)(C)c3ccccc3-4)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ GAA P10253 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ EPHX2 P34913 2/20 0.32
▸ NPSR1 Q6W5P4 3/20 0.32
▸ HTT P42858 2/20 0.32
▸ RCE1 Q9Y256 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ PDK2 Q15119 2/20 0.32
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ PGR P06401 1/20 0.31
▸ CNR2 P34972 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19098021 0.96 LMNA (0.36) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19098029 0.96 LMNA (0.36) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19098342 0.96 LMNA (0.36) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19098210 0.95 LMNA (0.39) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL23691171 0.95 LMNA (0.39) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19098203 0.95 ALDH1A1 (0.32) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19098027 0.95 ALDH1A1 (0.32) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19089907 0.94 LMNA (0.35) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19090001 0.94 LMNA (0.35) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19089960 0.94 LMNA (0.35) LMNAALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941108-B2 Organic compound and organic electroluminescent element comprising same MATERIAL SCIENCE CO., LTD. 2021-03-09 — — US disclosed
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-17 — — US disclosed
WO-2017116167-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 머티어리얼사이언스 주식회사 2017-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10941108-B2 Organic compound and organic electroluminescent element comprising same OCIAD2, OR51E2, OCIAD1 LMNA 2950/4885ALDH1A1 277/4885GAA 846/4885
US-20190016666-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OCIAD2, OR51E2, OCIAD1 LMNA 2950/4885ALDH1A1 277/4885GAA 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback